Effects of the oriental herbal medicine Bofu-tsusho-san in obesity hypertension: a multicenter, randomized, parallel-group controlled trial (ATH-D-14-01021.R2).

[1]  Alan D. Lopez,et al.  Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2014, The Lancet.

[2]  Yutaka Imai,et al.  Added Predictive Value of Night-Time Blood Pressure Variability for Cardiovascular Events and Mortality: The Ambulatory Blood Pressure–International Study , 2014, Hypertension.

[3]  Gianfranco Parati,et al.  Assessment and management of blood-pressure variability , 2014, Nature Reviews Cardiology.

[4]  Y. Toya,et al.  Effects of Single Pill-Based Combination Therapy of Amlodipine and Atorvastatin on Within-Visit Blood Pressure Variability and Parameters of Renal and Vascular Function in Hypertensive Patients with Chronic Kidney Disease , 2014, BioMed research international.

[5]  Y. Toya,et al.  Bofu-Tsu-Shosan, an Oriental Herbal Medicine, Exerts a Combinatorial Favorable Metabolic Modulation Including Antihypertensive Effect on a Mouse Model of Human Metabolic Disorders with Visceral Obesity , 2013, PloS one.

[6]  M. Woodward,et al.  Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials , 2013, BMJ.

[7]  Y. Toya,et al.  L/N-Type Calcium Channel Blocker Cilnidipine Added to Renin-Angiotensin Inhibition Improves Ambulatory Blood Pressure Profile and Suppresses Cardiac Hypertrophy in Hypertension with Chronic Kidney Disease , 2013, International journal of molecular sciences.

[8]  R. de Caterina,et al.  Increased short-term blood pressure variability is associated with early left ventricular systolic dysfunction in newly diagnosed untreated hypertensive patients , 2013, Journal of hypertension.

[9]  T. Saibara,et al.  Bofutsushosan, a Japanese herbal (Kampo) medicine, attenuates progression of nonalcoholic steatohepatitis in mice , 2013, Journal of Gastroenterology.

[10]  A. Fontana,et al.  Serum Resistin, Cardiovascular Disease and All-Cause Mortality in Patients with Type 2 Diabetes , 2013, PloS one.

[11]  Pengqian Wang,et al.  Chinese herbal formulas for treating hypertension in traditional Chinese medicine: perspective of modern science , 2013, Hypertension Research.

[12]  H. Kobori,et al.  The angiotensin II type 1 receptor blocker olmesartan preferentially improves nocturnal hypertension and proteinuria in chronic kidney disease , 2013, Hypertension Research.

[13]  L. Igel,et al.  Obesity‐related hypertension: Pathogenesis, cardiovascular risk, and treatment—A position paper of the The Obesity Society and the American Society of Hypertension , 2013, Obesity.

[14]  R. Charnigo,et al.  Adipocyte Deficiency of Angiotensinogen Prevents Obesity-Induced Hypertension in Male Mice , 2012, Hypertension.

[15]  Qingbo Xu,et al.  Oxidation-specific biomarkers, prospective 15-year cardiovascular and stroke outcomes, and net reclassification of cardiovascular events. , 2012, Journal of the American College of Cardiology.

[16]  K. Hunt,et al.  The levels of MDA-LDL in circulating immune complexes predict myocardial infarction in the VADT study. , 2012, Atherosclerosis.

[17]  G. Parati,et al.  ANTIHYPERTENSIVE THERAPY : RENAL INJURY ( MR WEIR AND GL BAKRIS , SECTION EDITORS ) Blood Pressure Variability , Cardiovascular Risk , and Risk for Renal Disease Progression , 2012 .

[18]  M. Dietrich,et al.  Limitations in anti-obesity drug development: the critical role of hunger-promoting neurons , 2012, Nature Reviews Drug Discovery.

[19]  Y. Toya,et al.  Effects of Aliskiren‐Based Therapy on Ambulatory Blood Pressure Profile, Central Hemodynamics, and Arterial Stiffness in Nondiabetic Mild to Moderate Hypertensive Patients , 2012, Journal of clinical hypertension.

[20]  F. Rubino,et al.  Bariatric surgery for type 2 diabetes , 2012, The Lancet.

[21]  R. Cortes,et al.  Impact of cardiovascular risk factors and inflammatory status on urinary 8-OHdG in essential hypertension. , 2012, American journal of hypertension.

[22]  G. Parati,et al.  Arterial stiffness and 24 h ambulatory blood pressure monitoring in young healthy volunteers: the early vascular ageing Aristotle University Thessaloniki Study (EVA-ARIS Study). , 2011, Atherosclerosis.

[23]  N. Ahmadi,et al.  Effects of intense exercise and moderate caloric restriction on cardiovascular risk factors and inflammation. , 2011, The American journal of medicine.

[24]  S. Umemura,et al.  Effects of Multiple Factorial Intervention on Ambulatory BP Profile and Renal Function in Hypertensive Type 2 Diabetic Patients with Overt Nephropathy – A Pilot Study , 2011, Clinical and experimental hypertension.

[25]  N. Roberts,et al.  Relative effectiveness of clinic and home blood pressure monitoring compared with ambulatory blood pressure monitoring in diagnosis of hypertension: systematic review , 2011, BMJ : British Medical Journal.

[26]  G. Tsivgoulis,et al.  Time rate of blood pressure variation: a new factor associated with coronary atherosclerosis , 2011, Journal of hypertension.

[27]  J. DeLany,et al.  Effects of diet and physical activity interventions on weight loss and cardiometabolic risk factors in severely obese adults: a randomized trial. , 2010, JAMA.

[28]  K. Tsunekawa,et al.  Oxidative stress associated with rapid weight reduction decreases circulating adiponectin concentrations. , 2010, Endocrine journal.

[29]  E. O’Brien,et al.  Prognostic Value of Reading-to-Reading Blood Pressure Variability Over 24 Hours in 8938 Subjects From 11 Populations , 2010, Hypertension.

[30]  T. Ogihara,et al.  The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009) , 2009, Hypertension Research.

[31]  Z. Tabka,et al.  Effect of individualized weight‐loss programmes on adiponectin, leptin and resistin levels in obese adolescent boys , 2009, Acta paediatrica.

[32]  U. Siering,et al.  Long-term Effects of Weight-Reducing Interventions in Hypertensive Patients: Systematic Review and Meta-analysis , 2009 .

[33]  R. de Caterina,et al.  Awake Systolic Blood Pressure Variability Correlates With Target-Organ Damage in Hypertensive Subjects , 2007, Hypertension.

[34]  Ryusuke Inoue,et al.  Ambulatory blood pressure, blood pressure variability and the prevalence of carotid artery alteration: the Ohasama study , 2007, Journal of hypertension.

[35]  T. Mizoue,et al.  Body mass index and oxidative DNA damage: A longitudinal study , 2007, Cancer science.

[36]  G. Mancia,et al.  Long-Term Prognostic Value of Blood Pressure Variability in the General Population: Results of the Pressioni Arteriose Monitorate e Loro Associazioni Study , 2007, Hypertension.

[37]  D. Kang,et al.  Effect of short-term fasting on urinary excretion of primary lipid peroxidation products and on markers of oxidative DNA damage in healthy women. , 2006, Carcinogenesis.

[38]  I. Maruyama,et al.  Bofutsushosan, a traditional Chinese formulation, prevents intimal thickening and vascular smooth muscle cell proliferation induced by balloon endothelial denudation in rats. , 2005, Biological & pharmaceutical bulletin.

[39]  K. Yoshimoto,et al.  Efficacy of Bofu‐tsusho‐san, an oriental herbal medicine, in obese Japanese women with impaired glucose tolerance , 2004, Clinical and experimental pharmacology & physiology.

[40]  C. Bulpitt,et al.  Systolic blood pressure variability as a risk factor for stroke and cardiovascular mortality in the elderly hypertensive population , 2003, Journal of hypertension.

[41]  A. Yamashina,et al.  Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. , 2002, Hypertension research : official journal of the Japanese Society of Hypertension.

[42]  Roberto Sega,et al.  Blood pressure variability and organ damage in a general population: results from the PAMELA study (Pressioni Arteriose Monitorate E Loro Associazioni). , 2002, Hypertension.

[43]  M. Kikuya,et al.  Prognostic Significance of Blood Pressure and Heart Rate Variabilities: The Ohasama Study , 2000, Hypertension.

[44]  G Parati,et al.  Ambulatory Blood Pressure Monitoring and Organ Damage , 2000, Hypertension.

[45]  B. Conrad,et al.  Relationship Between Circadian Blood Pressure Patterns and Progression of Early Carotid Atherosclerosis: A 3-Year Follow-Up Study , 2000, Circulation.

[46]  K Nagai,et al.  Factors that affect blood pressure variability. A community-based study in Ohasama, Japan. , 1997, American journal of hypertension.

[47]  N. Sakane,et al.  Thermogenic, anti-obesity effects of bofu-tsusho-san in MSG-obese mice. , 1995, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[48]  Yutaka Imai,et al.  The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014) , 2014, Hypertension Research.

[49]  K. Shimamoto.  The Japanese Society of Hypertension Guidelines for the Management of Hypertension 2014 (JSH2014) , 2014 .

[50]  S. Sakao,et al.  Spontaneously remitted pulmonary arterial hypertension associated with the herbal medicine "bofutsushosan". , 2013, Internal medicine.

[51]  S. Pierdomenico,et al.  Prognostic value of different indices of blood pressure variability in initially treated hypertensive patients , 2009 .

[52]  C. Koebnick,et al.  Increase in serum resistin during weight loss in overweight subjects is related to lipid metabolism , 2006, International Journal of Obesity.